Last checked at 22 Mar 2017 08:51
22 MARCH 2017
|
NOTIFICATION OF MAJOR INTEREST BY ALTO INVEST
ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that it has received notification by Alto Invest ("Alto") confirming its holding in ImmuPharma of 5,802,317 million Ordinary Shares in the capital of the Company, representing 4.38% of ImmuPharma's total voting rights figure of 132,522,985 Ordinary Shares.
Commenting, Tim McCarthy, Chairman of ImmuPharma, said: "We are delighted to be able to disclose Alto's increased holding in ImmuPharma as a further key major institutional investor which participated in our recent successful £4.1 million fundraising demonstrating its continued support for ImmuPharma."
Ends
For further information please contact:
|